| Katylynn B Hymas, PMHNP | |
|
535 S Humboldt St, Battle Mountain, NV 89820-1988 | |
| (775) 635-2424 | |
| Not Available |
| Full Name | Katylynn B Hymas |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 535 S Humboldt St, Battle Mountain, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669928347 | NPI | - | NPPES |
| 831647 | Other | NV | PROFESSIONAL LICENSE |
| CS30532 | Other | NV | CONTROLLED SUBSTANCE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN79742 (Nevada) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 831647 (Nevada) | Primary |
| Entity Name | Battle Mountain General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487729083 PECOS PAC ID: 6901710144 Enrollment ID: O20031113000113 |
News Archive
Employers prepared to pick up the cost of providing treatment for depression amongst their workers could reap benefits in terms of improved productivity and greater job retention.
Measuring the blood plasma levels of an enzyme called PDIA1 could one day become a method of diagnosing a person's predisposition to cardiovascular disease even if they are healthy, i.e., not obese, diabetic or a smoker, and with normal cholesterol.
Qualcomm Incorporated, a leading developer and innovator of advanced wireless technologies, products and services, has signed a memorandum of understanding with the Korea Centers for Disease Control and Prevention to provide high-tech applications and smartphones that will contribute to improving the convenience and efficiency of the national health survey.
The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that the external data and safety monitoring board (DSMB) has recommended that SNG001, an inhaled formulation of interferon beta, advance to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
› Verified 2 days ago
| Entity Name | Balanced Mental Wellness Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386332542 PECOS PAC ID: 7214391267 Enrollment ID: O20230911001136 |
News Archive
Employers prepared to pick up the cost of providing treatment for depression amongst their workers could reap benefits in terms of improved productivity and greater job retention.
Measuring the blood plasma levels of an enzyme called PDIA1 could one day become a method of diagnosing a person's predisposition to cardiovascular disease even if they are healthy, i.e., not obese, diabetic or a smoker, and with normal cholesterol.
Qualcomm Incorporated, a leading developer and innovator of advanced wireless technologies, products and services, has signed a memorandum of understanding with the Korea Centers for Disease Control and Prevention to provide high-tech applications and smartphones that will contribute to improving the convenience and efficiency of the national health survey.
The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that the external data and safety monitoring board (DSMB) has recommended that SNG001, an inhaled formulation of interferon beta, advance to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katylynn B Hymas, PMHNP 535 S Humboldt St, Battle Mountain, NV 89820-1988 Ph: (775) 635-2424 | Katylynn B Hymas, PMHNP 535 S Humboldt St, Battle Mountain, NV 89820-1988 Ph: (775) 635-2424 |
News Archive
Employers prepared to pick up the cost of providing treatment for depression amongst their workers could reap benefits in terms of improved productivity and greater job retention.
Measuring the blood plasma levels of an enzyme called PDIA1 could one day become a method of diagnosing a person's predisposition to cardiovascular disease even if they are healthy, i.e., not obese, diabetic or a smoker, and with normal cholesterol.
Qualcomm Incorporated, a leading developer and innovator of advanced wireless technologies, products and services, has signed a memorandum of understanding with the Korea Centers for Disease Control and Prevention to provide high-tech applications and smartphones that will contribute to improving the convenience and efficiency of the national health survey.
The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that the external data and safety monitoring board (DSMB) has recommended that SNG001, an inhaled formulation of interferon beta, advance to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
› Verified 2 days ago
Frank Uche Akpati, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 535 S Humboldt St, Battle Mountain, NV 89820 Phone: 775-635-2550 |